1. 4P FDG PET derived metabolic tumor volume (MTV) and its transcriptomic correlates as biomarker to predict efficacy of immune checkpoint inhibitors (ICB) alone or in combination with chemotherapy in advanced NSCLC: A multicentric study. (December 2022) Authors: Dall'Olio, F.G.; Garcia, C.A.; Zrafi, W.S.; Fortunati, E.; Bettayeb, A.; Zalcman, G.; Remon Masip, J.; Hendriks, L.; Tagliamento, M.; Bonardel, G.; Helissey, C.; Roelants, V.; Fourquet, A.; Aboubakar, F.; Chaput-Gras, N.; Passiglia, F.; Monnet, I.; Planchard, D.; Barlesi, F.; Besse, B. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Detection of myeloid malignancies through cfDNA profiling in patients with advanced stage cancer. (October 2022) Authors: Tagliamento, M.; Aldea, M.; Verge, V.; Bayle, A.; Blanc-Durand, F.; Marinello, A.; Hadoux, J.; Loriot, Y.; Vasseur, D.; Nicotra, C.; Smolenschi, C.; Martin-Romano, P.; Hollebecque, A.; Ponce, S.; Lacroix, L.; Rouleau, E.; Marzac, C.; Italiano, A.; Besse, B.; Micol, J.B. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions. (October 2022) Authors: Marinello, A.; Vasseur, D.; Conci, N.; Lindsay, C.; Metro, G.; Ferrara, R.; Eisert, A.; Citarella, F.; Fallet, V.; Audugier-Valette, C.; Cousin, S.; Tabbò, F.; Russo, A.; Calles Blanco, A.; Iranzo Gomez, P.; Tagliamento, M.; Mezquita, L.; Ponce, S.; Besse, B.; Aldea, M. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗